Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aditya Juloori

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Clinical Lung Cancer|July 7, 2020
Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung CancerSarah M C Sittenfeld, Aditya Juloori, Chandana A Reddy, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node MetastasesDaniel Thomas Ginat, Aditya Juloori, Omar I Vivar, et al.
Practical Radiation Oncology|March 4, 2015
Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage small cell lung cancerJonathan D Grant, Shervin M Shirvani, Chad Tang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 11, 2022
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer ImmunotherapyTaokun Luo, Geoffrey T Nash, Xiaomin Jiang, et al.
Practical Radiation Oncology|June 17, 2018
Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedulePamela Samson, Sana Rehman, Aditya Juloori, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2024
Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 TrialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapyAditya Juloori, Susan L Tucker, Ritsuko Komaki, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2024
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2013
Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancerShervin M Shirvani, Aditya Juloori, Pamela K Allen, et al.
American Journal of Clinical Oncology|April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot StudyShireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Clinical Lung Cancer|July 7, 2020
Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung CancerSarah M C Sittenfeld, Aditya Juloori, Chandana A Reddy, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node MetastasesDaniel Thomas Ginat, Aditya Juloori, Omar I Vivar, et al.
Practical Radiation Oncology|March 4, 2015
Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage small cell lung cancerJonathan D Grant, Shervin M Shirvani, Chad Tang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 11, 2022
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer ImmunotherapyTaokun Luo, Geoffrey T Nash, Xiaomin Jiang, et al.
Practical Radiation Oncology|June 17, 2018
Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedulePamela Samson, Sana Rehman, Aditya Juloori, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2024
Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 TrialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapyAditya Juloori, Susan L Tucker, Ritsuko Komaki, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2024
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2013
Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancerShervin M Shirvani, Aditya Juloori, Pamela K Allen, et al.
American Journal of Clinical Oncology|April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot StudyShireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
Pageof 6